About Summit Ivonescimab known as SMT112 is a novel potential first in class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD 1 with the anti angiogenesis effects associated with blocking VEGF into a single molecule Ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity when in the presence of both PD 1 and VEGF Summit has begun its clinical development of ivonescimab in non small cell lung cancer NSCLC with three active Phase III trials HARMONi is a Phase III clinical trial which intends to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR mutated locally advanced or metastatic non squamous NSCLC who have progressed after treatment with a 3rd generation EGFR TKI eg osimertinib HARMONi 3 is a Phase III clinical trial which is designed to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first line metastatic NSCLC HARMONi 7 is a Phase III clinical trial which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first line metastatic NSCLC whose tumors have high PD L1 expression Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summits license territories including the United States and Europe Ivonescimab was approved for marketing authorization in China in May 2024 Ivonescimab was granted Fast Track designation by the US Food & Drug Administration FDA for the HARMONi clinical trial setting Overview of Role The Associate Director Project Management CMC Quality is an individual contributor position that will play a critical role in driving the success of Summit programs and with prioritized focus in CMC Supply Quality and Business activities This role will provide CMC Quality program leadership in cross functional team settings and will help build the infrastructure tools and processes contributing to the success of Program Management department They will provide strategic and operational leadership for CMC and Quality deliverables across the biologics development lifecyclefrom early clinical phases through BLA submission and post approval changes Working within a matrixed environment this position will collaborate across Process Development Analytical Development Quality Regulatory Affairs Manufacturing external partners CDMOsCROs to deliver high quality submissions and commercialization readiness This role requires flexible execution focused capabilities with the ability to take on additional responsibilities as the departmentcompany grow
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level
Industry
Chemical Manufacturing